🇺🇸 FDA
Patent

US 8962677

Methods of restoring cognitive ability using non-peptidic compounds

granted A61KA61K31/00A61K31/34

Quick answer

US patent 8962677 (Methods of restoring cognitive ability using non-peptidic compounds) held by Acumen Pharmaceuticals, Inc. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acumen Pharmaceuticals, Inc.
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/00, A61K31/34, A61K31/381, A61K31/415